Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of BMS-833923 in Basal Cell Nevus Syndrome
NCT02100371Completed
- Sponsor
- University Health Network
- Start
- Feb 2014
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of BMS-833923 in Basal cell nevus syndrome (BCNS), sponsored by University Health Network. Primary endpoint: Frequency of side effects experienced per participant up to 5 years. Started Feb 2014; status: completed.
02
Drugs
BMS-833923
03
Conditions
Basal cell nevus syndrome (BCNS)
Beyond the preview
Go deeper on NCT02100371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100371.